Don’t Throw Manual Lymphatic Drainage Out With the Volume

Certified lymphedema therapists (CLTs) have been debating that recent evidence-based studies do not recommend manual lymphatic drainage (MLD) as an essential component to complete decongestive therapy (CDT). The overarching conclusion to abandon MLD in clinical practice primarily focuses on the lack of evidence that MLD reduces volume. This commentary aims to address the non-MLD narrative and offer a different perspective in support of MLD as an essential component of CDT. The narrative that MLD does not reduce volume is a moot point because that never was the implication to disprove from the beginning. MLD increases lymph production, increases lymphangiomotoricity, increases venous return, stimulates the autonomic nervous system, and facilitates the immune system. CDT consists of a combination of several treatments, including MLD, which are all equally important when administered properly. Discernment is recommended when applying the non-MLD narrative to clinical practice.

Authors

Institutions

Publication Details

Journal
Rehabilitation Oncology
Published
2025-04-01
DOI
https://doi.org/10.1097/01.reo.0000000000000386
Primary Topic
Lymphatic System and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Don’t Throw Manual Lymphatic Drainage Out With the Volume

David Doubblestein, Linda Koehler
Rehabilitation Oncology
Lymphatic System and Diseases
article

Don’t Throw Manual Lymphatic Drainage Out With the Volume

David Doubblestein, Linda Koehler
article en

Abstract

Certified lymphedema therapists (CLTs) have been debating that recent evidence-based studies do not recommend manual lymphatic drainage (MLD) as an essential component to complete decongestive therapy (CDT). The overarching conclusion to abandon MLD in clinical practice primarily focuses on the lack of evidence that MLD reduces volume. This commentary aims to address the non-MLD narrative and offer a different perspective in support of MLD as an essential component of CDT. The narrative that MLD does not reduce volume is a moot point because that never was the implication to disprove from the beginning. MLD increases lymph production, increases lymphangiomotoricity, increases venous return, stimulates the autonomic nervous system, and facilitates the immune system. CDT consists of a combination of several treatments, including MLD, which are all equally important when administered properly. Discernment is recommended when applying the non-MLD narrative to clinical practice.

Rehabilitation OncologyVol. 43(2)
University of Minnesota (US), A.T. Still University (US)
Openalex Percentile: Top 89%
Lymphatic System and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.